Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Henkel

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
The British Journal of Dermatology|January 20, 2005
Angiokeratomas, Fabry disease and enzyme replacement therapy: still a challengeM Möhrenschlager, V Henkel, J Ring
Lancet (London, England)|May 23, 2000
Lessons from the Hampshire Depression ProjectV Henkel, D Althaus, U Hegerl
MMW Fortschritte Der Medizin|July 4, 2001
[Diagnosis and therapy of depression. Key role for the family physician]V Henkel, V Wambach, H J Möller, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 27, 2002
Cognitive-behavioural theories of helplessness/hopelessness: valid models of depression?V Henkel, P Bussfeld, H-J Möller, et al.
European Journal of Clinical Investigation|July 17, 2004
Fabry outcome survey: need for documentation of dermatological, ophthalmological and psychiatric affectionsM Möhrenschlager, H Henkel, J Ring, et al.
Nucleic Acids Research|September 25, 2004
DNA computing using single-molecule hybridization detectionKristiane A Schmidt, Christiaan V Henkel, Grzegorz Rozenberg, et al.
Bioinformatics (Oxford, England)|December 15, 2010
Scaffolding pre-assembled contigs using SSPACEMarten Boetzer, Christiaan V Henkel, Hans J Jansen, et al.
Physiological Genomics|September 18, 2014
Using normalization to resolve RNA-Seq biases caused by amplification from minimal inputEirill Ager-Wick, Christiaan V Henkel, Trude M Haug, et al.
Royal Society Open Science|March 29, 2020
Swimming exercise enhances brain plasticity in fishDaan Mes, Arjan P Palstra, Christiaan V Henkel, et al.
Pharmacopsychiatry|February 12, 2005
Randomized, double-blind study of SR142801 (Osanetant). A novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challengesG Kronenberg, P Berger, R F Tauber, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
The British Journal of Dermatology|January 20, 2005
Angiokeratomas, Fabry disease and enzyme replacement therapy: still a challengeM Möhrenschlager, V Henkel, J Ring
Lancet (London, England)|May 23, 2000
Lessons from the Hampshire Depression ProjectV Henkel, D Althaus, U Hegerl
MMW Fortschritte Der Medizin|July 4, 2001
[Diagnosis and therapy of depression. Key role for the family physician]V Henkel, V Wambach, H J Möller, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 27, 2002
Cognitive-behavioural theories of helplessness/hopelessness: valid models of depression?V Henkel, P Bussfeld, H-J Möller, et al.
European Journal of Clinical Investigation|July 17, 2004
Fabry outcome survey: need for documentation of dermatological, ophthalmological and psychiatric affectionsM Möhrenschlager, H Henkel, J Ring, et al.
Nucleic Acids Research|September 25, 2004
DNA computing using single-molecule hybridization detectionKristiane A Schmidt, Christiaan V Henkel, Grzegorz Rozenberg, et al.
Bioinformatics (Oxford, England)|December 15, 2010
Scaffolding pre-assembled contigs using SSPACEMarten Boetzer, Christiaan V Henkel, Hans J Jansen, et al.
Physiological Genomics|September 18, 2014
Using normalization to resolve RNA-Seq biases caused by amplification from minimal inputEirill Ager-Wick, Christiaan V Henkel, Trude M Haug, et al.
Royal Society Open Science|March 29, 2020
Swimming exercise enhances brain plasticity in fishDaan Mes, Arjan P Palstra, Christiaan V Henkel, et al.
Pharmacopsychiatry|February 12, 2005
Randomized, double-blind study of SR142801 (Osanetant). A novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challengesG Kronenberg, P Berger, R F Tauber, et al.
Pageof 5